Low-Density Lipoprotein Cholesterol Testing Following Myocardial Infarction Hospitalization Among Medicare Beneficiaries
Authors' conclusion
LDL-C testing following MI hospital discharge among Medicare beneficiaries was low.
Study context
- Population
- Medicare beneficiaries ≥66 years with myocardial infarction (MI) hospitalization, 2016–2020
- Participants
- 532,767 MI hospitalizations
- Outcome
- Proportion of Medicare beneficiaries with LDL-C measured after MI hospital discharge
- Follow-up
- Within 90 days following MI hospital discharge
Main finding
As reported in the abstract
LDL-C testing within 90 days post-discharge
Beneficiaries with low-density lipoprotein cholesterol (LDL-C) measured (FFS with pharmacy benefits)
29.9%
Observational data: associations, not effects.
Further findings
| Outcome | Values |
|---|---|
| 90-day LDL-C testing by race/ethnicity | Hispanic 33.8% · Asian 32.5% · Non-Hispanic White 30.0% · Non-Hispanic Black 26.0% |
| 90-day LDL-C testing by US region · highest and lowest regions | Middle Atlantic 36.4% · West North Central 23.4% |
| 90-day LDL-C testing, secondary cohorts | FFS without pharmacy benefits 26.9% · Medicare Advantage 28.6% |
- 90-day LDL-C testing, secondary cohorts: FFS without pharmacy benefits: 5% random sample, 10,394 MI hospitalizations
- 90-day LDL-C testing, secondary cohorts: Medicare Advantage: 176,268 MI hospitalizations
Original publication
Low-Density Lipoprotein Cholesterol Testing Following Myocardial Infarction Hospitalization Among Medicare Beneficiaries. JACC Adv. Published 8 December 2023. doi:10.
Composed by AI from the published abstract and checked against it. How Briefs are made →